Amneal Pharmaceuticals Inc (AMRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 CROSSING BOULEVARD BRIDGEWATER, NJ 08807

Amneal Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company specializes in developing, manufacturing, marketing, and distributing generic and biosimilar pharmaceutical products. Amneal Pharmaceuticals serves clients worldwide.

Data as of 2020-08-09
Market Cap1.32 Billion Shares Outstanding299.656 Million Avg 30-day Volume1.32 Million
P/E Ratio Dividend Yield EPS-1.56
Price/Sales0.511 Price cash flow ratio3.8 Price free cash flow ratio-9.3
Book Value1.06 Price to Tangible Book-0.79 Alpha-0.04
Short Interest Ratio4.91 % Short Interest to Float2.3 R-squared0.265677
BETA2.09028 52-week High/Low5.79 / 2.27 Stddev0.170531

Are you looking for this stock instead?

View SEC Filings from AMRX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 128 38 (2.49%)
Aggregate 13F shares on 03/31/2020: 97.221 Million 32.256 Million
Aggregate 13F shares on 12/31/2019: 101.154 Million 34.477 Million
Percent change: -3.89% -6.44%
Funds creating new positions: 27 13
Funds Adding to an existing position: 38 7
Funds closing out their position: 28 12
Funds reducing their position: 36 14
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AMRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

55.8 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • Director
  • 10% Owner
18,716,306 2020-08-06 0

VERGIS JANET S.

  • Director
12,941 2020-08-04 0

MEISTER PAUL M

  • Director
27,923 2020-08-02 4

BOYER ANDREW S EXECUTIVE VICE PRESIDENT

  • Officer
109,933 2020-08-01 5

BRANNING TODD P. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-07-13 3

BISARO PAUL

  • Director
0 2020-06-18 0

BUCHI J KEVIN

  • Director
0 2020-06-15 1

KIELY JOHN

  • Director
10,000 2020-05-19 4

GEORGE JEFFREY P.

  • Director
23,810 2020-05-15 4

KONIDARIS TASOS

0 2020-05-13 2

YANAI SHLOMO

  • Director
5,290 2020-05-12 3

TODISCO JOSEPH SVP, SPECIALTY COMMERCIAL

  • Officer
254,024 2020-05-07 5

PATEL CHINTU CO-CEO AND DIRECTOR

  • Officer
  • Director
  • 10% Owner
362,566 2020-05-07 4

PATEL CHIRAG K. PRESIDENT, CO-CEO & DIRECTOR

  • Officer
  • Director
  • 10% Owner
362,566 2020-05-07 4

SHAH NIKITA SVP, CHIEF HR OFFICER

  • Officer
179,727 2020-05-07 4

PATEL GAUTAM

  • Director
  • 10% Owner
13,049,999 2020-05-05 3

NARK TED C

  • Director
62,566 2020-05-05 2

ALVA EMILY PETERSON

  • Director
12,566 2020-05-05 1

TERRERI PETER R

  • Director
82,758 2020-05-04 1

MANZANO STEPHEN SVP, GENERAL COUNSEL

  • Officer
0 2020-02-27 2

BUCHEN DAVID A SVP, CHIEF LEGAL OFFICER

  • Officer
20,426 2020-01-03 1

FOSUN INTERNATIONAL LTD

  • 10% Owner
23,819,500 2019-12-06 0

BHADAURIA PRADEEP SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-11-13 2

STEWART ROBERT A PRESIDENT AND CEO

  • Officer
  • Director
78,668 2019-05-07 0

RAMA DHARMENDRA

  • Director
6,107 2019-05-06 0

BURR ROBERT L

  • Director
102,639 2019-05-06 0

GREENE JEAN SELDEN

  • Director
6,107 2019-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MEISTER PAUL M - Director

2020-08-02 M 27,923 a 27,923 27,923.00 direct

MEISTER PAUL M - Director

2020-08-02 M 27,923 d 0 27,923.00 direct

MEISTER PAUL M - Director

2020-08-02 M 27,923 d 0 27,923.00 direct

MEISTER PAUL M - Director

2020-08-02 M 27,923 a 27,923 27,923.00 direct

BOYER ANDREW S - Officer EXECUTIVE VICE PRESIDENT

2020-08-01 A 69,284 a 102,595 109,933.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.58% 2018-06-13 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.63% 2018-05-25 GERMANY
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.54% 2018-05-23 GERMANY

Elevate your investments